Lobbying Filing Details

Total Spending

$802,333

Activities

7

Lobbyists

8

Gov't Entities

35

Filing Information
Filing UUID:
04883984-327c-45e8-858d-f6df6bfaad37
Type:
Q2 - 2nd Quarter - Report
Period:
2016 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 19, 2016 at 8:16 PM
Income:
$0
Expenses:
$802,333
Expense Method:
Method C - Reporting amounts under section 162(e) of the Internal Revenue Code
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
ASSOCIATION FOR ACCESSIBLE MEDICINES

Association representing the interests of the generic pharmaceutical industry.

Washington, District of Columbia
Client
ASSOCIATION FOR ACCESSIBLE MEDICINES
District of Columbia, United States of America
Lobbying Activities (7)
Activity 1
Budget/Appropriations

FDA Funding.
S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017.
H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017.
H.R.1314: Bipartisan Budget Act of 2015.
S.2837: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017.
S.3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017.
H.R.3020: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016.

Lobbyists (4)
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHRISTOPHER BOWLIN
  • CHRISTIAN OMAR CRUZ
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 2
Copyright/Patent/Trademark

Inter Partes Review (IPR) process.

Lobbyists (3)
  • HEIDI WILSON
  • MICHAEL BRZICA
  • THOMAS JAMES GARRIGAN
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 3
Health Issues

Innovation for Healthier Americans Initiative.
H.R.6: 21st Century Cures Act.

Lobbyists (6)
  • CHRISTINE SIMMON
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHRISTOPHER BOWLIN
  • THOMAS JAMES GARRIGAN
  • CHRISTIAN OMAR CRUZ
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Medicare/Medicaid

Medicare Part D Program and Generic Drugs.
Medicare reimbursement for biosimilars.
H.R.1314: Bipartisan Budget Act of 2015.
Covered Outpatient Drugs (CMS-2345-FC).
CMMI Part B Drug Demo.

Lobbyists (6)
  • CHRISTINE SIMMON
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHRISTOPHER BOWLIN
  • THOMAS JAMES GARRIGAN
  • CHRISTIAN OMAR CRUZ
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 5
Pharmacy

Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA).
Labeling of Generic Drugs.
Biosimilars Naming.
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products.
Prescription Drug Costs.
H.R.2841: FAST Generics Act of 2015.
H.R.1314: Bipartisan Budget Act of 2015.
Drug Importation.
Risk Evaluation and Mitigation Strategies (REMS).
Biologic Exclusivity.
Biologics Price Competition and Innovation Act (BPCIA).
S.2615: Increasing Competition in Pharmaceuticals Act.
Pharmaceutical exclusivity.
H.R.4931: Pharmaceutical Stewardship Act of 2016.
H.R.953: Comprehensive Addiction and Recovery Act of 2015 (CARA).
S.3056: CREATES Act of 2016.

Lobbyists (8)
  • CHRISTINE SIMMON
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHESTER DAVIS JR
  • CHRISTOPHER BOWLIN
  • KATHRYN LEE ANDERSON CHADWICK
  • THOMAS JAMES GARRIGAN
  • CHRISTIAN OMAR CRUZ
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 6
Taxation/Internal Revenue Code

Taxation Issues Related to Opioid Pharmaceuticals.
S.3075: Addiction Prevention and Responsible Opioid Practices Act.
S.2977: Budgeting for Opioid Addiction Treatment Act.

Lobbyists (3)
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHRISTIAN OMAR CRUZ
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 7
Trade (domestic/foreign)

Trans-Pacific Partnership (TPP).
Biologic Exclusivity.

Lobbyists (3)
  • HEIDI WILSON
  • MICHAEL BRZICA
  • KATHRYN LEE ANDERSON CHADWICK
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)

Source: LDA.gov, data retrieved November 4, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.